Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma
- ACS Med Chem Lett. 2023 Sep 19;14(10):1336-1337. doi: 10.1021/acsmedchemlett.3c00393.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 37849559
DOI: 10.1021/acsmedchemlett.3c00393
Abstract
Provided herein are novel pyrazolopyrazine compounds as SHP2 inhibitors, pharmaceutical compositions, use of such compounds in treating glioblastoma, and processes for preparing such compounds.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
-
-
-
-